IlluminaDx is committed to the rapidly growing field of molecular diagnostics. Leveraging our extensive knowledge of science and cutting-edge technology, we are relentless in the creation of innovative products to enhance the quality of life for mankind. IlluminaDx is developing various multiplexed, accurate, and cost-effective nucleic acid tests (NATs) that will be used to diagnose and manage human diseases. Our plans will initially focus on human infectious diseases and cytogenetics. We will ultimately extend into oncology to support cancer therapy management through diagnostic, prognostic, staging, and therapeutic monitoring.
The BeadXpress system is the first 510(k)-cleared IlluminaDx in vitro diagnostic (IVD) device. It is intended for the simultaneous detection of multiple analytes in a DNA sample using VeraCode holographic microbead technology. The BeadXpress system consists of the BeadXpress Reader and VeraScan software. It is cleared for use only with FDA-cleared VeraCode tests.